Atlas Trials

Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease

Clinical trial NCT04805099 · COMPLETED

Trial details

NCT number
NCT04805099
Sponsor
Hellenic Cooperative Oncology Group
Status
COMPLETED
Study type
OBSERVATIONAL
Autoimmune DiseasesCheckpoint InhibitorImmunotherapy
Start date
2020-11-01
Primary completion
2021-01-30
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.